Alzheimer’s is usually framed as plaques and tangles—but this Deep Dive goes upstream: mitochondrial failure and impaired mitophagy. Dr. Mike Belkowski breaks down mitophagy as the brain’s selective mitochondrial cleanup system—and why neurons are uniquely vulnerable when damaged mitochondria can’t be transported, tagged, and fully degraded.

You’ll learn how mitophagy appears impaired across multiple steps in Alzheimer’s (initiation, recruitment, transport, lysosomal fusion, and degradation), how hallmark factors like tau, amyloid-beta, APP fragments (APP-CTFs), and APOE4 can jam the machinery, and why the real therapeutic target may be mitophagy flux—not just turning the process “on,” but ensuring cleanup completes from start to finish. The episode closes with a systems-based framework for breaking the loop: reduce chronic stressors, support mitochondrial signaling, and prioritize lifestyle levers that promote mitochondrial quality control.

(Educational content only, not medical advice.)

Article Discussed in Episode:

Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches

Key Quotes From Dr. Mike:

“Alzheimer’s isn’t just plaques and tangles — it’s also a story about energy failure.”

“Mitophagy is selective mitochondrial cleanup.”

“If you don’t remove broken mitochondria, they don’t sit quietly—they leak.”

“You can’t just ask, ‘Is mitophagy turned on?’ You have to ask, ‘Is mitophagy completing?’”

“Damaged mitochondria accumulate → more oxidative stress → more energy failure → worse cleanup.”

“The future isn’t just ‘turn on mitophagy.’ It’s support mitophagy flux from start to finish.”

Key points

Mitophagy = selective mitochondrial cleanup (tag → wrap → lysosome → recycle).
In neurons, cleanup is harder: lysosomes are mainly in the soma, so damaged mitochondria in axons must be transported back.
In Alzheimer’s, damaged mitochondria accumulate, especially near synapses → ROS, calcium disruption, inflammation, ATP loss.
Evidence summarized: Alzheimer’s brains show reduced mitophagy signatures + structurally damaged mitochondria (cristae disruption, low ATP).
Mitophagy impairment can occur at multiple failure points (initiation → LC3 recruitment → AMPK/ULK1/TBK1 signaling → lysosomal fusion).
Key principle: initiation ≠ completion; if lysosomal fusion fails, you get “garbage bags with no pickup.”
Transport deficits (incl. DISC1-related trafficking roles) can worsen mitochondrial congestion.
Alzheimer’s proteins can jam mitophagy: tau (PINK1/Parkin interference), amyloid-beta (context-dependent; flux often blocked downstream).
APP-CTFs may correlate strongly with mitophagy marker changes and may disrupt mitochondria-associated membranes (MAMs).
APOE4 links to autophagy/lysosomal dysfunction, a major bottleneck for clearance.
Therapeutic direction: not just “boost mitophagy,” but support mitophagy flux + lysosomal capacity + brain penetration.
Biggest levers aren’t only compounds—exercise, fasting-style metabolic stress, rhythm/sleep are core mitophagy signals; chronic stressors crush it.

Episode timeline

0:19–1:45 — Frame: Alzheimer’s as energy + cleanup failure; define mitophagy
1:45–2:45 — Neuron logistics: soma lysosomes, axonal transport, synaptic vulnerability
2:45–4:20 — Evidence: impaired mitophagy markers + damaged mitochondria; “completion vs initiation”
4:20–5:15 — Transport issues (DISC1) and multi-step failure points
5:15–8:15 — Mapping AD factors to mitophagy failure: tau, amyloid, APP-CTFs/MAMs, APOE4
8:15–9:40 — The vicious loop (mitochondria ↔ ROS ↔ inflammation ↔ clearance failure)
9:40–11:35 — Breaking the loop: flux-first strategy; compounds under investigation; bottlenecks
11:35–14:10 — Lifestyle levers + Biolite “mitochondria stack” framing; systems-based takeaway

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

Stay up-to-date on social media:

Dr. Mike Belkowski:

BioLight: